You are here: Industry Insights > biosimilar

News List

Chemotherapy uptake to gradually decrease with arrival of novel therapies and biosimilars- GlobalData expresspharma
March 26, 2021
Trends in chemotherapy sales are expected to vary widely with CAGRs ranging from -14.92 per cent to 8.40 per cent across 15 major.
mAbxience Expands Biosimilar and CDMO Manufacturing Capacity contractpharma
March 26, 2021
ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, said that mAbxience will equip their state-of-the-art cGMP facility in León, Spain with an ABEC 4,000L Custom Single Run (CSR) Bioreactor.
Mylan-UpJohn merger as Viatris provides opportunity to focus on biosimilar launch and uptake expresspharma
March 17, 2021
Following the news that the European Medicines Agency (EMA) has approved Kixelle, Biocon/Mylan’s biosimilar of Novo Nordisk’s Novolog/NovoRapid (insulin aspart).
Cipla Gulf expands partnership with Alvotech for commercialisation of biosimilars in Australia and New Zealand expresspharma
March 02, 2021
Cipla has announced that it’s subsidiary, Cipla Gulf is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand.
Abu Dhabi firm, ADQ invests Rs 555 crores in Biocon Biologics expresspharma
January 11, 2021
Biocon Biologics had raised over $255 million from global investors from Jan to Nov 2020.
USFDA defers action on BLA for Avastin biosimilar, notifies Biocon Biologics, Mylan expresspharma
December 28, 2020
To complete the application, the agency noted that an inspection of the manufacturing facility is required as a part of the standard review process.
The Biden effect on India Pharma Inc expresspharma
December 02, 2020
Stakeholders share their views and insights on the impact of a change of guard at the White House and outline India Pharma Inc's expectations from the Biden administration.
SomaLogic Announces New Collaboration with FDA to Advance Biosimilar Development americanpharmaceuticalreview
November 09, 2020
SomaLogic announced an agreement with the U.S. Food and Drug Administration’s (FDA) Division of Applied Regulatory Science to evaluate the utility of large-scale analysis of proteins (proteomics) for the identification of biomarkers that may be useful ...
EMA accepts filing for Biogen/Samsung Bioepis’ Lucentis biosimilar pharmatimes
October 10, 2020
The European Medicines Agency (EMA) has accepted for review the marketing authorisation for Biogen and Samsung Bioepis’ biosimilar referencing Genentech's Lucentis (ranibizumab).
Alvotech and DKSH Extend Biosimilar Partnership in Asia contractpharma
September 27, 2020
Initial pipeline contains biosimilar candidates addressing multiple therapeutic areas.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page